LSE - Delayed Quote GBp

BSF Enterprise Plc (BSFA.L)

Compare
2.5000
-0.2500
(-9.09%)
At close: January 10 at 4:11:23 PM GMT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
12.9420
12.9420
--
--
--
Cost of Revenue
71.3240
71.3240
--
--
--
Gross Profit
-58.3820
-58.3820
--
--
--
Operating Expense
1,510.1040
1,510.1040
751.6990
58.2180
93.7580
Operating Income
-1,568.4860
-1,568.4860
-751.6990
-58.2180
-93.7580
Net Non Operating Interest Income Expense
-11.9630
-11.9630
-2.1460
-0.1070
-0.0870
Pretax Income
-1,580.4490
-1,580.4490
-929.4320
-58.3250
-93.8450
Tax Provision
-79.4070
-79.4070
0.6070
--
--
Net Income Common Stockholders
-1,501.0420
-1,501.0420
-930.0390
-58.3250
-93.8450
Diluted NI Available to Com Stockholders
-1,501.0420
-1,501.0420
-930.0390
-58.3250
-93.8450
Basic EPS
-0.02
-0.02
-0.02
-0.00
-0.01
Diluted EPS
-0.02
-0.02
-0.02
-0.00
-0.01
Basic Average Shares
94,654.0120
94,654.0120
45,109.1960
20,340.0020
20,340.0020
Diluted Average Shares
94,654.0120
94,654.0120
45,109.1960
20,340.0020
20,340.0020
Total Operating Income as Reported
-1,570.3080
-1,570.3080
-927.3220
-58.3250
--
Total Expenses
1,581.4280
1,581.4280
751.6990
58.2180
93.7580
Net Income from Continuing & Discontinued Operation
-1,501.0420
-1,501.0420
-930.0390
-58.3250
-93.8450
Normalized Income
-1,501.0420
-1,501.0420
-787.8135
-58.3250
-93.8450
Interest Expense
10.1410
10.1410
2.1100
--
--
Net Interest Income
-11.9630
-11.9630
-2.1460
-0.1070
-0.0870
EBIT
-1,570.3080
-1,570.3080
-927.3220
-58.2180
-93.7580
EBITDA
-1,461.2350
-1,461.2350
-905.8000
-58.2180
-93.7580
Reconciled Cost of Revenue
71.3240
71.3240
--
--
--
Reconciled Depreciation
109.0730
109.0730
21.5220
--
--
Net Income from Continuing Operation Net Minority Interest
-1,501.0420
-1,501.0420
-930.0390
-58.3250
-93.8450
Total Unusual Items Excluding Goodwill
--
--
-175.5870
--
--
Total Unusual Items
--
--
-175.5870
--
--
Normalized EBITDA
-1,461.2350
-1,461.2350
-730.2130
-58.2180
-93.7580
Tax Rate for Calcs
0.0001
0.0001
0.0002
--
--
Tax Effect of Unusual Items
--
--
-33.3615
--
--
9/30/2020 - 7/26/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PBDA.DU Protalix BioTherapeutics Inc
2.1150
-1.90%
 
SCLP.L Scancell Holdings plc
10.10
+3.59%
 
AVCT.L Avacta Group Plc
51.00
0.00%
 
RPTX Repare Therapeutics Inc.
1.3800
+7.81%
 
KPTI Karyopharm Therapeutics Inc.
0.7186
+0.36%
 
BCAB BioAtla, Inc.
0.5316
-5.07%
 
TLSA Tiziana Life Sciences Ltd
0.8400
+14.13%
 
MRSN Mersana Therapeutics, Inc.
0.7200
-44.62%
 
FGEN FibroGen, Inc.
0.6160
-5.35%
 
PLX Protalix BioTherapeutics, Inc.
2.2700
0.00%